KR20190059525A - Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof - Google Patents
Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof Download PDFInfo
- Publication number
- KR20190059525A KR20190059525A KR1020170157205A KR20170157205A KR20190059525A KR 20190059525 A KR20190059525 A KR 20190059525A KR 1020170157205 A KR1020170157205 A KR 1020170157205A KR 20170157205 A KR20170157205 A KR 20170157205A KR 20190059525 A KR20190059525 A KR 20190059525A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- goat
- quercetin
- ginsenoside
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/808—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package for immersion in the liquid to release part or all of their contents, e.g. tea bags
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명에서는 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이 등의 활성형 진세노사이드와 생리활성성분인 클로르제닉산 및 쿼르세틴이 현저히 증진된 산양삼 전초차 및 그 제조방법이 개시된다. 본 발명의 산양삼 전초차는 항산화 활성, 항당뇨 활성 및 항비만 활성이 증진되어 기능성 식품의약품의 소재로 사용될 수 있으며, 지방생성 억제효과, 체중 조절, 콜레스테롤 저하, 고지혈증 개선, 동맥경화 완화, 당뇨병 완화, 혈액순환 개선, 면역력 개선용으로 유용하다.
본 발명에 따른 산양삼 전초차는 기호성 또한 우수하고, 산양삼의 잎과 줄기를 포함하는 전초를 이용함에 의해 경제적으로도 매우 효율적이다.The present invention discloses active ginsenosides such as ginsenosides F2, Rg3, Rh2, and Compound K, and ginseng ginseng supernatant in which chlorogenic acid and quercetin, which are physiologically active components, are significantly enhanced, and a preparation method thereof. The ginseng root extract of the present invention can be used as a material for functional food products by enhancing antioxidant activity, anti-diabetic activity and anti-obesity activity. It can be used for preventing fat production, controlling body weight, decreasing cholesterol, improving hyperlipidemia, It is useful for improving blood circulation and improving immunity.
The goat ginseng outpour according to the present invention is also excellent in palatability and is economically very efficient by using outposts containing leaves and stems of goat ginseng.
Description
본 발명은 활성형 진세노사이드, 클로르제닉산 및 쿼르세틴이 강화된 산양삼 전초차 및 그 제조방법에 관한 것으로, 더 상세하게는 산양삼을 부위별로 특정조건의 덖음을 거치도록 제조하여, 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이 등의 활성형 진세노사이드와 생리활성성분인 클로르제닉산 및 쿼르세틴이 현저히 증진된 산양삼 전초차 및 그 제조방법에 관한 것이다.The present invention relates to an active ginsenoside, a chlorogenic acid and a quercetin-enriched ginseng root pre-plantation, and a method for preparing the same. More specifically, the present invention relates to a ginseng root preparation, F2, Rg3, Rh2, and Compound K, chlorogenic acid as a physiologically active ingredient, and quercetin, and a method for producing the same.
일반적으로 차(茶)의 의미는 차나무의 어린잎을 따서 만든 마실 거리의 재료, 또는 마른 차가 물과 어울려서 만들어진 마실 거리 찻물을 뜻한다. 이러한 차는 인류의 역사와 더불어 민간 의약용으로 오랜 세월동안 질병치료의 목적으로 이용되다가 점차 경험적인 효능이 인정되면서 음료로 정착되어 왔으며, 현재 차는 커피 및 코코아와 함께 3세대 비알코올성 기초음료로서 세계 인구의 50% 정도가 마시고 있다. 또한 최근에는 차가 일상생활에서 예절 등 사회의 문화와 정신적인 면에서뿐만 아니라 영양공급과 노화억제, 생체리듬 조절, 면역력 증진 등 복잡한 생명활동을 조절하는 기능성이 과학적으로 규명됨에 따라 기능성 식품으로서의 가치가 제고되고 있다.Generally, the meaning of a tea is the material of a drink made from the young leaf of a tea tree, or the drink tea made by mixing a dried tea with water. These tea, along with human history, have been used for the treatment of diseases for a long time as a civilian medicine, and have been established as beverages with gradually recognized empirical efficacy. Now tea, along with coffee and cocoa, are the third generation non- About 50% of people drink. Recently, tea has been scientifically identified as a function to control complex life activities such as nutrition, aging control, biorhythm control, and immunity enhancement, as well as culture and spiritual aspects such as etiquette in everyday life. .
고려인삼의 속명인 Panax는 그리스어의 Pan(모든)과 Akok(치료하다)의 복합어로서 '모든 병을 치료한다'라는 의미로 예로부터 식약용으로 가장 널리 이용되고 있는 약용작물이다. 인삼은 약 60%의 탄수화물, 8~15%의 조단백질, 1~3%의 조지방, 4~6%의 회분, 3~7%의 조사포닌, 그 외 미량성분들로 구성되어 있다. 삼(蔘)은 중추신계를 비롯하여 내분비계, 면역계, 대사계 등에 영향을 미쳐 신체기능 조절에 다양한 약리효과를 나타낸다고 보고되어 있으며, 이와 같은 약리효과는 특히 활성 진세노사이드에 기인하는 것으로 알려져 있다.Panax, the name of Korean ginseng, is a compound of Greek Pan (all) and Akok (cure). It is the most widely used medicinal plant for medicinal purposes since ancient times. Ginseng consists of about 60% carbohydrates, 8 ~ 15% crude protein, 1 ~ 3% crude fat, 4-6% ash, 3-7% crude saponin and other trace elements. Ginseng has been reported to exhibit various pharmacological effects on the control of body function by influencing the central nervous system, endocrine system, immune system, metabolism system, and such pharmacological effect is known to be caused by active ginsenoside.
활성형 진세노사이드는 인체 장내에서 흡수가 용이한 진세노사이드로서 진세노사이드 Rg1, Rg3, Rd, Rf, Rh, F2, 컴파운드 케이(compound K) 등이 있다. 진세노사이드 Rg1은 학습기능 개선, 항피로 작용, 진세노사이드 Rf는 뇌신경세포 진통작용, 지질과산화 억제작용, 진세노사이드 Rg3는 암세포 전이억제, 간보호 작용, 항암제 내성억제 작용, 진세노사이드 Rd는 부신피질 호르몬 분비 촉진 작용, 진세노사이드 컴파운드 케이는 항암작용, 간보호 작용, 피부보호 작용, 종양증식억제 작용, 항산화 작용, 항알레르기 작용이 밝혀져 있다. 특히, 진세노사이드 컴파운드 케이 (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol)는 진세노사이드 대사체로서 특히 체내 흡수율이 탁월하고 약리학적 활성도 우수한 것으로 알려져 있으며, 최근에는 황반변성질환 치료, 신경변증성 통증 치료도 보고되고 있다 (등록특허 10-1539573).Active ginsenosides are ginsenosides Rg1, Rg3, Rd, Rf, Rh, F2 and compound K, which are readily absorbed in the human intestinal tract. Ginsenoside Rg1 is a compound of the present invention which is effective in improving learning function, antipyretic action, ginsenoside Rf is a neuronal cell analgesic action, lipid peroxidation inhibitory action, ginsenoside Rg3 inhibits cancer cell metastasis, liver protective action, , Ginsenoside compound k is anticancer, liver protection, skin protection, tumor growth inhibition, antioxidant, and antiallergic activity. In particular, 20-O-beta-D-glucopyranosyl-20 (S) -protopanaxadiol is a ginsenoside metabolite, which is known to be excellent in absorption rate and pharmacological activity, Disease treatment, and neuropathic pain treatment have also been reported (Patent No. 10-1539573).
그러나 이들 활성형 진세노사이드는 삼 자체에는 거의 함유되어 있지 않아, 이를 해결하고자 효소나 장내 미생물을 이용하여 삼에 포함된 진세노사이드를 활성형으로 전환하는 기술들이 몇몇 개발되어 있으나 (등록특허 10-1751305, 등록특허 10-0811295), 이들 기술은 비용이 높거나 활성형 진세노사이드의 증진율이 낮은 문제를 내포하고 있어서, 여전히 활성형 진세노사이드가 증진된 삼 가공품의 개발이 요구되고 있는 실정이다.However, these active-type ginsenosides are rarely contained in the trimesters. To solve this problem, some technologies have been developed to convert ginsenosides contained in the trimesoides into active forms by using enzymes or intestinal microorganisms (Patent No. 10 -1751305, Patent No. 10-0811295), these techniques involve the problem of high cost or low rate of active ginsenoside development, and there is a demand for the development of three processed products with enhanced active ginsenosides It is true.
쿼르세틴(quercetin)은 플라보놀 화합물의 일종으로 항염증작용, 뇌세포 보호활성, 항암작용, 항당뇨, 항비만, 항고혈압 등 각종 생리활성을 나타내는 것으로 보고되어 있고, 클로르제닉산(chlorgenic acid)은 페놀산의 일종으로, 활성산소를 제거하고 혈당을 저하하여 항당뇨 활성을 나타내는 것으로 보고되어 있다. 그러나 삼 가공품과 관련하여서는 진세노사이드 이외에 폴리페놀 화합물이나 페놀산 증진에 관한 기술이 개발된 바가 드물다. Quercetin is a type of flavonol compound which has been reported to exhibit various physiological activities such as antiinflammatory action, brain cell protective activity, anticancer activity, antidiabetic activity, anti-obesity and antihypertensive effect, and chlorgenic acid, Is a kind of phenolic acid, which has been reported to exhibit antidiabetic activity by removing active oxygen and lowering blood sugar. However, in relation to the three processed products, techniques for enhancing polyphenol compounds or phenolic acid in addition to ginsenosides have been rarely developed.
삼에 대한 선호도가 인삼에서 홍삼으로 그리고 최근에는 무농약 산양삼(야생삼)으로 변화하고 있어 산양삼을 이용한 기능성식품의 요구가 급증하고 있는 실정이다.The preference for ginseng is changing from ginseng to red ginseng and recently to non - pesticidal goat ginseng (wild ginseng), so the demand for functional food using goat ginseng is increasing rapidly.
이에 본 발명자들은 종래 기술의 요구에 부응하기 위한 연구를 지속한 결과, 산양삼을 부위별로 특정조건의 덖음을 거치도록 제조한 산양삼 전초차는 활성형 진세노사이드인 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이와 생리활성성분인 클로르제닉산 및 쿼르세틴이 현저히 증진됨을 확인하고 본 발명을 완성하게 되었다.As a result of continuing the research to meet the demand of the prior art, the inventors of the present invention have found that the goat ginseng outpowder prepared so as to undergo specific conditions of the goat ginseng by site is composed of the active ginsenosides ginsenoside F2, Rg3, Rh2, K and physiologically active components, chlorgenic acid and quercetin, were significantly improved, and the present invention was completed.
따라서 본 발명의 목적은 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이의 활성형 진세노사이드와 생리활성성분인 클로르제닉산 및 쿼르세틴이 증진된 산양삼 전초차의 제조방법을 제공하는 것이다.Accordingly, an object of the present invention is to provide a method for preparing active ginsenosides of ginsenosides F2, Rg3, Rh2 and compound k, and chlorogenic acid and quercetin, which are physiologically active components, from a ginseng root.
본 발명의 또 다른 목적은 상기 제조방법에 의해 제조된, 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이의 활성형 진세노사이드와 생리활성성분인 클로르제닉산 및 쿼르세틴이 증진된 산양삼 전초차를 제공하는 것이다.It is still another object of the present invention to provide a method for producing the ginsenoside F2, Rg3, Rh2 and Compound K, which is produced by the above-described method, which comprises the active ginsenosides of the compound k, the chlorogenic acid which is a physiologically active ingredient, .
상기 목적을 달성하기 위하여, 본 발명은 본 발명은 하기와 같은 단계들을 포함하는 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이와 클로르제닉산 및 쿼르세틴이 증진된 산양삼 전초차의 제조방법을 제공한다:In order to accomplish the above object, the present invention provides a method for preparing ginsenosides F2, Rg3, Rh2, and compound k, chlorogenic acid and quercetin-enhanced goat ginseng precursor comprising the following steps :
i) 산양삼 전초를 증숙하는 단계; i) mashing the outpouring of the goat ginseng;
ii) 증숙된 산양삼 지하부(뿌리)는 180∼220℃에서 5∼15분 덖음 및 40~50℃ 냉각을 2~3회 반복하는 단계; ii) Repeating the roots of the mixed ginseng roots at a temperature of 180 to 220 ° C for 5 to 15 minutes and cooling at 40 to 50 ° C for 2 to 3 times;
ⅲ) 증숙된 산양삼 지상부(잎과 줄기)는 130∼160℃에서 5∼15분 덖음 및 40~50℃ 냉각을 2~3회 반복하는 단계; 및Iii) Repeating the boiled goat's gills (leaves and stems) at a temperature of 130 to 160 ° C for 5 to 15 minutes and cooling at 40 to 50 ° C for 2 to 3 times; And
ⅳ) 덖음된 산양삼 지상부와 산양삼 지하부를 혼합하는 단계. Ⅳ) Mixing the bittered ginseng root with the ginseng root.
필요에 따라서, 본 발명의 제조방법은, v) 건조하는 단계, ⅵ) 포장하는 단계를 추가로 포함할 수 있다.If desired, the manufacturing method of the present invention may further comprise: v) drying; and vi) packaging.
본 발명에서 ‘산양삼’은 산지에서 차광막 등 인공시설을 설치하지 아니하고 무농약으로 재배되는 삼을 의미한다.In the present invention, 'ginseng ginseng' refers to a plant that is cultivated in an organic pesticide rather than an artificial facility such as a shade screen.
본 발명에서 '전초(全草)'는 산양삼의 뿌리, 줄기 및 잎을 포함한 전체를 의미하고, ‘지상부’는 산양삼의 재배시 지상에 위치된 부분인 ‘줄기와 잎’을 의미하고, ‘지하부’는 산양삼의 재배시 지하에 위치된 부분인 ‘뿌리’를 의미한다. In the present invention, 'whole grass' refers to all the roots, stems and leaves of the goat ginseng, and 'above ground' means 'stem and leaf' which is located on the ground when the goat ginseng is cultivated, 'Means' root' which is a part located underground when cultivating goat ginseng.
단계 ⅰ): 산양삼 전초 증숙Step i):
산양삼 전초를 증숙(steaming process)한다.Steaming process of the outpost of the goat ginseng.
산양삼 전초는 3년근 이상을 사용하고, 더 바람직하게는 3년근의 산양삼 전초를 사용한다.The outpost of the goat ginseng is more than 3 years old, more preferably 3 years old goat ginseng outpost is used.
산양삼을 흐르는 물에 3회 세척하고 물기를 제거한 후, 산양삼의 지상부(잎과 줄기)와 지하부(뿌리)로 분리한 후 3~5cm 두께로 절단하여 증숙한다. 3cm 이하로 절단의 경우 덖음 처리 시 탈수 있고, 5cm 이상의 경우 고루 덖음 처리가 되지 않을 수 있다.After washing the goat's ginseng with water three times and removing the water, the goat's ginseng is divided into the ground (leaves and stem) and the root (root), and cut into 3 ~ 5cm thick. Cutting to 3cm or less may be dehydrated when it is processed, but not more than 5cm.
증숙은 통상의 찜기와 같은 증숙기를 사용하여 수행할 수 있으며, 80∼100℃에서 20∼60분간 증숙한다.The steaming can be carried out using a steam boiler such as a conventional steamer, and the steaming at 80 to 100 ° C for 20 to 60 minutes.
증숙시간이 20분 미만인 경우 산양삼에 충분한 수분이 공급이 되지 않아 덖음 처리 시 고루 덖음 처리가 처리되지 않으며, 60분 이상의 경우 과한 증숙으로 조직이 연화되어 덖음 처리가 제대로 이루어지 않을 수 있다.When the steaming time is less than 20 minutes, sufficient water is not supplied to the goat's ginseng so that it is not treated at the time of tasting, and if it is more than 60 minutes, the tasting process may not be performed properly due to excessive tasting.
단계 ⅱ) 산양삼 지하부 덖음Step ii)
증숙된 산양삼 지하부(뿌리)는 180∼220℃에서 5∼15분 덖음 및 40~50℃ 냉각을 2~3회 반복한다. The roots of the mixed ginseng roots are roasted at 180 ~ 220 ℃ for 5 ~ 15 minutes and cooled at 40 ~ 50 ℃ for 2 ~ 3 times.
바람직하게는 산양삼 뿌리는 200℃에서 5∼15분 덖음 및 40~50℃ 냉각을 2회 반복한다.Preferably, the ginseng roots are repeated twice at 200 占 폚 for 5 to 15 minutes and cooled at 40 to 50 占 폚.
이와 같은 처리에 의해 활성 진세노사이드 및 생리활성성분이 증진될 뿐만 아니라 산양삼의 쌉싸래한 맛을 제거하고 구수한 맛이 부여되어 기호성이 우수해질 수 있다.By such treatment, not only the active ginsenosides and physiologically active ingredients are promoted, but also the delicate taste of the goat's ginseng is removed, and a palatable taste is imparted, whereby the palatability can be improved.
덖음은 차의 품질을 결정하는 가장 중요한 공정으로 열처리 온도, 시간의 조절에 따라서 차의 수분함량, 성분 및 맛이 변화된다. 따라서 동일한 재료에 만들어진 차라도 덖음 방식에 따라서 기호성과 기능성이 달라진다. It is the most important process to determine the quality of tea, and the moisture content, composition and taste of tea are changed according to heat treatment temperature and time. Therefore, even if the tea is made from the same material, palatability and functionality vary depending on the method of sake.
단계 ⅲ) 산양삼 지상부 덖음Step iii)
증숙된 산양삼 지상부(잎과 줄기)는 130∼160℃에서 5∼15분 덖음 및 40~50 ℃ 냉각을 2~3회 반복한다.Repeat 2 ~ 3 times at 130 ~ 160 ℃ for 5 ~ 15 minutes and 40 ~ 50 ℃ cooling.
바람직하게는 산양삼 잎과 줄기는 150℃에서 5∼15분 덖음 및 40~50℃ 냉각을 3회 반복한다. Preferably, the goat's leaves and stalks are washed three times at 150 ° C for 5 to 15 minutes and cooled to 40 to 50 ° C.
이와 같은 덖음 처리에 의해 연약한 잎이 탄화하는 현상에 따른 유해성분(벤조피렌, 니토로사민 등)의 발생을 방지할 수 있고, 활성 진세노사이드 및 생리활성성분이 증진될 뿐만 아니라 산양삼의 쌉싸래한 맛을 제거하고 구수한 맛이 부여되어 기호성이 우수해질 수 있다.By such softening treatment, it is possible to prevent the generation of harmful components (benzopyrrene, nitrosamine, etc.) due to the phenomenon that soft leaves are carbonized, and not only the active ginsenosides and physiologically active ingredients are promoted, Can be removed, and a palatable taste can be imparted, so that palatability can be enhanced.
또한 상기의 덖음 처리에 의해 산양삼 전초 내에 결합되어 있던 페놀릭스, 플라보노이드, 갈변물질, 페놀산 및 플라보놀이 유리되어 함량이 증가한다.In addition, the content of phenolics, flavonoids, browning substances, phenolic acid, and flavonol, which were bound in the outpouring of the goat ginseng, was increased by the above-mentioned tillering treatment.
실제 삼의 잎과 줄기에는 다량의 진세노사이드 성분이 함유되어 있으나 인삼의 경우 다년간 재배에 따른 다량의 농약 사용으로 잎과 줄기를 사용할 수 없으나, 무농약으로 재배되는 산양삼의 잎과 줄기는 상기와 같은 덖음 처리에 의해 함유하고 있는 다량의 진세노사이드를 활성 진세노사이드로 전환하여 증진시켜 활용할 수 있게 된다. In fact, leaves and stems of leaves contain large amounts of ginsenosides, but in the case of ginseng, leaves and stems can not be used because of the large amount of pesticides used for many years of cultivation. However, It is possible to convert a large amount of ginsenoside contained in the ginseng to an active ginsenoside and enhance it for utilization.
단계 ⅳ): 혼합Step iv): Mixing
덖음된 산양삼 지상부와 산양삼 지하부를 혼합하여 산양삼 전초차를 제조한다. Mixed ginseng ginseng ground and undergrowth of goat ginseng to prepare goat ginseng tea.
덖음된 산양삼 지상부 : 덖음된 산양삼 지하부 혼합비는 1 ~ 10 : 10 ~ 1(w/w)이며, 바람직하게는 6~4 : 4~6 이다. The mixed ratio of the raw goat's godlings is 1 to 10:10 to 1 (w / w), preferably 6 to 4: 4 to 6.
상기와 같은 혼합비로 혼합된 산양삼 전초차는 기호성이 우수하면서도 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이와 클로르제닉산 및 쿼르세틴의 함량이 현저히 증진되어, 항산화 활성, 항당뇨 및 항비만 활성이 강화된다. The ginseng pre-tea mixed at the mixing ratio as described above is excellent in palatability, and the contents of ginsenosides F2, Rg3, Rh2, compound k, chlorigenic acid and quercetin are remarkably enhanced and antioxidant activity, antidiabetic activity and anti-obesity activity are enhanced do.
단계 v): 건조Step v): Drying
필요에 따라서, 제조된 산양삼 전초차는 저장성을 높이기 위해 수분이 완전히 제거되도록 건조를 실시한다.If necessary, the prepared goat ginseng tea is dried so as to completely remove moisture to improve storage stability.
건조에 앞서, 필요에 따라서, 산양삼 전초차는 0.1∼0.5 cm로 분쇄한 후 건조할 수 있다. Prior to drying, if necessary, the ginseng pre-tea may be pulverized to 0.1 to 0.5 cm and then dried.
0.1∼0.5 cm로 분쇄 시 통상의 티백차 제조에 용이하고 또한 뜨거운 물로 효율적으로 차물을 우려낼 수 있다.When it is pulverized to 0.1 to 0.5 cm, it is easy to produce ordinary tea bags, and the tea can be efficiently removed with hot water.
건조는 통상적인 방법으로 건조될 수 있으며, 바람직하게는 50 ~ 60℃에서 1 ~ 3일간 건조한다. The drying can be carried out by a conventional method, preferably at 50 to 60 DEG C for 1 to 3 days.
단계 ⅵ): 포장Step vi): Packaging
필요에 따라서, 제조된 산양삼 전초차를 포장한다. If necessary, pack the prepared goat ginseng tea.
포장은 산양삼 전초차를 그대로 지퍼팩, 캔 또는 병에 넣거나 티백 포장지로 포장하여 제품화할 수 있으며, 이에 한정되지 않고 당업계에서 상용되는 포장 기술은 제한 없이 사용될 수 있다.The packaging can be put into a zipper pack, a can or a bottle, or packed with a teabag wrapping paper, and the packaging technology commonly used in the art can be used without limitation.
본 발명의 상기와 같은 단계를 거쳐 제조된 산양삼 전조차는 가공 전에 비하여 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이 함량이 각각 최대 약 1.6배, 2.2배, 2.1배, 2.4배 증진되고, 클로니제닉산의 함량은 최대 약 2.2배, 쿼르세틴의 함량은 약 3.4배 증진된다 (표 2, 3).The ginsenoside F2, Rg3, Rh2 and compound k contents were increased by about 1.6 times, 2.2 times, 2.1 times, and 2.4 times, respectively, as compared to that before processing, The content of genic acid is increased up to 2.2 times and the content of quercetin is increased 3.4 times (Table 2, 3).
본 발명의 또 다른 목적은 본 발명의 제조방법에 따라 제조된, 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이 등의 활성형 진세노사이드와 생리활성성분인 클로르제닉산 및 쿼르세틴이 증진된 산양삼 전초차를 제공한다. It is still another object of the present invention to provide a method for producing an active ginsenoside, such as ginsenoside F2, Rg3, Rh2 and Compound K, which is produced according to the method of the present invention and a physiologically active component, chlorogenic acid and quercetin- Provide outposts.
본 발명에 따른 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이와 클로르제닉산 및 쿼르세틴이 증진된 산양삼 전초차는 진세노사이드 F2를 약 5 mg/g 이상, 진세노사이드 Rg3를 약 0.7 mg/g 이상, 진세노사이드 컴파운드 케이를 약 0.7 mg/g 이상, 진세노사이드 Rh2를 약 1 mg/g 이상 함유하고, 클로르제닉산을 약 60 ㎍/g 이상 함유하고, 쿼르세틴을 약 150 ㎍/g 이상 함유한다 (표 2, 3).The ginsenosides F2, Rg3, Rh2 and the compound k and the chlorogenic acid and quercetin-enhanced ginseng root precursor according to the present invention have a concentration of not less than about 5 mg / g of ginsenoside F2, about 0.7 mg / g of ginsenoside Rg3 Or more, a ginsenoside compound K of about 0.7 mg / g or more, ginsenoside Rh2 of about 1 mg / g or more, chlorogenic acid of about 60 占 퐂 / g or more and quercetin of about 150 占 퐂 / g More than (Table 2, 3).
본 발명에 따른 산양삼 전초차는 증진된 활성형 진세노사이드, 클로르제닉산을 포함한 페놀산 및 쿼르세틴를 포함한 플라보놀, 및 갈변물질의 함량이 강화되어, 증진된 항산화 활성, 항당뇨 활성 및 항비만 활성을 갖는다.The ginseng outpowder according to the present invention has an enhanced antioxidant activity, antidiabetic activity, and anti-obesity activity by enhancing the content of enhanced active ginsenoside, phenolic acid including chlorogenic acid, flavonol including quercetin, Respectively.
본 발명에 따른 산양삼 전초차는 티백 형태로 포장되어 제품화될 수 있다. 포장은 상기에서 정의된 바와 같다.The goat ginseng tea according to the present invention can be packaged in the form of a tea bag to be commercialized. The packaging is as defined above.
본 발명에 따른 제조방법은, 통상의 방법에 비하여, 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이와 클로르제닉산 및 쿼르세틴의 함량이 현저히 증진된 산양삼 전초차를 생산케 한다.The production method according to the present invention produces ginsenoside F2, Rg3, Rh2, and compound K, a ginseng ginseng extract having significantly increased contents of chlorogenic acid and quercetin, as compared with the conventional method.
본 발명에 따른 산양삼 전초차는 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이의 활성형 진세노사이드와 생리활성성분인 클로르제닉산 및 쿼르세틴의 함량이 현저히 증진되어 있고, 더불어 우수한 알파-글루코시다제 저해활성과 췌장 리파제 저해활성도 가져서 항산화 활성, 항당뇨 활성 및 항비만 활성이 증진되어 기능성 식품·의약품의 소재로 사용될 수 있으며, 지방생성 억제효과, 체중 조절, 콜레스테롤 저하, 고지혈증 개선, 동맥경화 완화, 당뇨병 완화, 혈액순환 개선, 면역력 개선용으로 유용하다.The ginseng root extract according to the present invention is characterized in that the contents of active ginsenosides of ginsenosides F2, Rg3, Rh2 and compound k, chlorogenic acid and quercetin as physiologically active components are remarkably improved, and excellent alpha-glucosidase Inhibitory activity and pancreatic lipase inhibitory activity, and thus can be used as a material for functional foods and medicines by enhancing antioxidant activity, antidiabetic activity and anti-obesity activity, and can be used as a material for inhibiting fat production, controlling body weight, decreasing cholesterol, improving hyperlipemia, It is useful for relieving diabetes, improving blood circulation, and improving immunity.
본 발명에 따른 산양삼 전초차는 기호성 또한 우수하고, 산양삼의 잎과 줄기를 포함하는 전초를 이용함에 의해 경제적으로도 매우 효율적이다.The goat ginseng outpour according to the present invention is also excellent in palatability and is economically very efficient by using outposts containing leaves and stems of goat ginseng.
도 1은 본 발명에 따른 산양삼 전초차의 제조 공정의 일례를 나타낸 사진이다.
도 2는 본 발명에 따른 산양삼 전초차의 진세노사이드 HPLC 크로마토그램을 나타낸 것이다. 도 2a는 산양삼 잎과 줄기인 지하부의 진세노사이드 HPLC 크로마토그램을 나타낸 것이며, 도 2b는 산양삼 뿌리인 지상부의 진세노사이드 HPLC 크로마토그램을 나타낸 것이다.
도 3은 본 발명에 따른 산양삼 전초차의 생리활성물질 함량을 나타낸 것이다. 도 3a는 총 페놀릭스 함량을 나타낸 것이며, 도 3b는 총 플라보노이드스 함량을 나타낸 것이며, 도 3c는 갈변물질 함량을 나타낸 것이다.
도 4는 본 발명에 따른 산양삼 전초차의 항산화 활성을 나타낸 것이다. 도 4a는 DPPH 라디칼 소거활성을 나타낸 것이며, 도 4b는 ABTS 라디칼 소거활성을 나타낸 것이며, 도 4c는 하이드록실 라디칼 소거활성을 나타낸 것이며, 도 4d는 FRAP 환원력을 나타낸 것이다.
도 5는 본 발명에 따른 산양삼 전초차의 소화효소 저해활성을 나타낸 것이다. 도 5a는 알파-글루코시다아제 저해활성을 나타낸 것이며, 도 5b는 췌장-리파아제 저해활성을 나타낸 것이다.1 is a photograph showing an example of a manufacturing process of a goat ginseng outpost according to the present invention.
2 shows the ginsenoside HPLC chromatogram of the goat ginseng outpost according to the present invention. FIG. 2A shows the ginsenoside HPLC chromatogram of the goat's leaves and stem, and FIG. 2B shows the ginsenoside HPLC chromatogram of the root of the goat's ginseng root.
FIG. 3 shows the content of physiologically active substance of the goat ginseng root according to the present invention. Figure 3a shows the total phenolic content, Figure 3b shows the total flavonoid content, and Figure 3c shows the browning material content.
4 shows the antioxidative activity of the goat ginseng root according to the present invention. FIG. 4A shows the DPPH radical scavenging activity, FIG. 4B shows the ABTS radical scavenging activity, FIG. 4C shows the hydroxyl radical scavenging activity, and FIG. 4D shows the FRAP reducing power.
Fig. 5 shows the digestive enzyme inhibitory activity of the goat ginseng root according to the present invention. Figure 5a shows the alpha-glucosidase inhibitory activity and Figure 5b shows the pancreatic-lipase inhibitory activity.
다음의 실시예들에 의해 본 발명이 더 상세히 설명된다. 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의해 제한되어서는 안된다.The present invention will be described in more detail by the following examples. These examples are for illustrating the present invention, and the scope of the present invention should not be limited by them.
제조예: 산양삼 전초차의 제조Production Example: Production of Saururus ganoderma
2010년 7 ~ 8월 함양군 서상면 일대의 해발 500m 이상에서 3년이상 재배된 산양삼 전초를 구하여 사용하였다. 산양삼 전초 5 kg를 흐르는 물에 3회 세척하고 물기를 제거한 후, 지상부(잎과 줄기)와 지하부(뿌리)로 분리한 후 3 ~ 5cm 두께로 절단하여, 찜기통에 담은 후 100℃에서 30분간 증숙하였다. From July to August, 2010, the outposts of the goat ginseng cultivated for over 3 years at over 500m above sea level were collected and used. (5 kg) was washed three times with flowing water, and the water was removed. The leaves were separated into the upper part (leaf and stem) and the root part (root), cut into 3-5 cm thick, placed in a steam bath, Matured.
증숙된 잎과 줄기의 지상부는 150℃에서 5분간 덖음 및 40~50℃ 냉각을 1회, 2회 및 3회 반복하였고, 뿌리인 지하부는 200℃에서 3분간 덖음 및 40~50℃ 냉각을 1회, 2회 및 3회 반복하였다. 그리고 나서 0.1∼0.5 cm로 분쇄한 후. 55℃에서 1일 건조하고 지상부와 지하부의 원료 무게 비율인 6 : 4로 덖음 처리한 지상부와 지하부를 혼합하여 산양삼 전초차를 제조하였다 (도 1).The root portion of the blasted leaves and stems were washed once at 150 ° C for 5 minutes and cooled at 40-50 ° C for 1, 2, and 3 times. The roots were washed at 200 ° C for 3 minutes and cooled at 40-50 ° C Times, 2 times and 3 times. Then, after crushing to 0.1 to 0.5 cm. Dried at 55 ° C for 1 day, and mixed with the ground part and the underground part, which had been treated with a raw material weight ratio of 6: 4 at the top and bottom parts, to prepare a goat ginseng pre-tea (FIG.
<이화학적 특성><Physicochemical properties>
제조된 산양삼 전초차의 pH는 pH 미터기를 사용하여 측정하였고, 총산도는 중화적정법을 통해 수행하여 젖산으로 환산하였고, 환원당은 DNS법(Mille, 1953)을 통해 수행하여 포도당으로 환산하여 표기하여 표 1에 나타내었다.The pH of the prepared goat ginseng seeds was measured using a pH meter, and the total acidity was calculated by the neutralization titration method and converted to lactic acid. Reducing sugar was converted to glucose by the DNS method (Mille, 1953) Respectively.
횟수Lull
Number of times
부위Goat
part
1)모든 실험은 삼 반복 수행하였음.* Root of leaves (stem and leaf) was treated once, twice and three times for 5 minutes at 150 ℃, and roots were treated once, twice and three times for 5 minutes at 200 ℃, After that, it was dried at 55 ° C for 3 days.
1) All experiments were repeated three times.
본 발명에 따라 제조된 산양삼 전초차는 원재료인 산양삼 전초에 비하여 pH는 감소하였고, 총산도와 환원당은 증가하였다. pH가 높을 경우에는 식품위해미생물 등의 증식이 가능하고, 너무 낮을 경우에는 과다 산이 생성되면 신맛이 강화하여 기호성에 문제가 발생할 수 있는데, 본 발명의 산양삼 전초차는 적당한 산과 당이 생성되어 신맛과 단맛이 적절히 이루어져 있다.The pH and the total acidity and reducing sugar of the goat ginseng tea prepared according to the present invention were lower than those of the raw goat ginseng. When the pH is high, it is possible to multiply the microorganism for food, and when it is too low, when the excessive acid is produced, the sour taste may be strengthened, The acidic ginseng pre-tea of the present invention is suitably composed of suitable acid and sugar to produce sour and sweet taste.
시험예 1. 진세노사이드 함량 분석Test Example 1. Analysis of ginsenoside content
상기에서 제조된 산양삼 전초차를 분쇄기로 100메쉬 이하로 분쇄하여 분말을 제조하였다. 참조예로서 사용하기 위하여 원재료 산양삼 전초를 동일한 방식으로 분말화하였다.The prepared goat ginseng tea was pulverized into a powder having a size of 100 mesh or less by a pulverizer. The raw material ginseng outpost was powdered in the same manner for use as a reference example.
<분석시료 준비><Preparation of analytical sample>
상기에서 제조된 분말은 건강기능식품분석법에 따라 삼 진세노사이드를 추출하였다. 구체적으로는 각 건조분말을 1 g씩 250 ml 삼각플라스크에 정확히 취하고 70% 메탄올 20 ml를 가하여 80℃ 항온수조에서 1시간 정치한 후 냉각하였다. 이를 원심분리하여 상등액만 취하고 이를 2회 반복하였다. 이 상등액을 60℃에서 감압 농축하여 그 잔유물을 3차 증류수 2 ml에 용해하여 0.45㎛ 멤브레인 필터로 여과한 후 분석시료로 사용하였다.The powder prepared above was extracted with tannic acid according to the method of health functional food analysis. Specifically, each dry powder was precisely weighed into a 250 ml Erlenmeyer flask (1 g), 20 ml of 70% methanol was added, allowed to stand in a constant temperature water bath at 80 ° C for 1 hour, and then cooled. This was centrifuged and the supernatant was taken and repeated twice. The supernatant was concentrated under reduced pressure at 60 ° C, the residue was dissolved in 2 ml of tertiary distilled water, filtered through a 0.45 μm membrane filter, and used as an analytical sample.
<진세노사이드 화합물 분석>≪ Analysis of ginsenoside compound >
진세노사이드 분석은 기능성식품 분석법에 기술된 방법을 변형하여 고압액체크로마토그래피(HPLC, high press liquid chromatograph)로 분석하였다. 분석 컬럼은 TSKgel ODS-100Z을 사용하여 시료주입량 10㎕, 온도는 30℃ 측정파장은 203 nm, 유속은 1.0 ml/min으로 하였고 이동상으로는 A용액은 HPLC water, B용액은 아세토니트릴을 사용하였다. HPLC 분석 조건은 이동상 용액은 0분때 A용액 81% : B용액 19%로 흘려주고 15분때에는 A용액 80% : B용액 20%로 흘려주고 40분때 A용액 77% : B용액 23%, 42분때 A용액 70% : B용액 30%, 75분때에 A용액 65% : B용액 35%, 80분때에 A용액 30% : B용액 70%, 90분때에 A용액 10% : B용액 90%로 이동상을 흘려주었다. 각 HPLC 크로마토그램을 도 2a (산양삼 전초차 중 지상부) 및 도 2b (산양삼 전초차 중 지하부)에 나타내고, 활성형 진세노사이드 화합물의 함량을 표 2에 나타내었다. The ginsenoside analysis was performed by modifying the method described in the functional food analysis method by high pressure liquid chromatograph (HPLC). The analytical column was TSKgel ODS-100Z at a sample injection volume of 10 μl, a temperature of 30 ° C, a wavelength of 203 nm and a flow rate of 1.0 ml / min. For the mobile phase, HPLC water was used for the A solution and acetonitrile was used for the B solution. For HPLC analysis, the mobile phase solution was flowed to the A solution 81%: B solution 19% at 0 minute, and the
1)모든 실험은 삼 반복 수행하였음.* Roast treatment of the upper part (leaf and stem) was treated once, twice and three times for 5 minutes at 150 ° C, and roasted at 150 ° C for 5 minutes once, twice and three times And then dried at 55 ° C for 3 days.
1) All experiments were repeated three times.
도 2 및 표 2에 나타낸 바와 같이, 산양삼 원료에 비하여, 산양삼 전초차의 활성형 진세노사이드인 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이의 함량은 현저히 증진되었다. As shown in Fig. 2 and Table 2, the content of ginsenosides F2, Rg3, Rh2 and compound k, which are active ginsenosides of goat ginseng pre-tea, was significantly increased as compared with the raw ginseng raw material.
지하부 (뿌리)의 경우 진세노사이드 F2, Rg3, Rh2 및 컴파운드 원료에 비하여 각각 2.5∼2.9배, 1.5∼4.2배, 1.6∼2.1배 및 1.6∼2.6배 증가하였다 (도 2b). In the case of the root (root), 2.5-2.9 times, 1.5-4.2 times, 1.6-2.1 times and 1.6-2.6 times higher than that of ginsenoside F2, Rg3, Rh2 and the compound raw material, respectively (Fig.
지상부 (잎과 줄기)의 경우 진세노사이드 F2, Rg3, Rh2 및 컴파운드 케이는 원료에 비하여 각각 1.1∼1.4배, 1.1∼1.7배, 1∼1.4배 및 1.3∼2.9배 증가하였다 (도 2a).The ginsenosides F2, Rg3, Rh2, and compound K increased 1.1 to 1.4 times, 1.1 to 1.7 times, 1 to 1.4 times, and 1.3 to 2.9 times, respectively, as compared with the raw materials (Fig.
산양삼 전초차의 경우 진세노사이드 F2, Rg3, Rh2 및 컴파운드 원료에 비하여 각각 1.2∼1.6배, 1.5∼2.2배, 1.4∼2.1배 및 1.4∼2.4배 증가하였다 (도 2c).(Fig. 2C), respectively, as compared with the ginsenosides F2, Rg3, Rh2 and the compound raw materials, respectively.
특히 지상부의 경우는 덖음 처리가 3회일 때, 지하부는 덖음 횟수가 2회일 때 활성형 진세노사이드가 가장 많이 증진되었다.Especially, in the ground part, the active type ginsenoside was most improved when the roasting was 3 times and the roasting frequency was 2 times.
시험예Test Example 2. 2. 산양삼Goat 전초차의Outpost 생리활성성분 함량 분석 Analysis of physiologically active ingredient content
산양삼 전초차의 항산화 활성 등을 나타내는 생리활성성분인 총 페놀릭스, 총 플라보노이드스, 갈변물질 함량을 분석하였다.Total phenolics, total flavonoids, and browning substances, which are physiologically active components, were analyzed.
<분석시료 준비><Preparation of analytical sample>
시험예 1에서와 같이 분말화한 각 분말 10 g에 50% 발효주정 10 ml를 첨가하여 상온(20±5℃)에서 24시간 추출하고 3,000 rpm의 속도로 원심분리하여 상등액만을 취하여 추출물을 제조하고 이 추출물을 시료로 하여 총 페놀릭스, 총 플라보노이드스 함량 분석을 하였다.10 ml of a 50% fermented alcohol was added to 10 g of each powder powder as in Test Example 1, and the mixture was extracted at room temperature (20 ± 5 ° C) for 24 hours and centrifuged at a rate of 3,000 rpm to prepare an extract. Total phenolics and total flavonoids were analyzed by using this extract as a sample.
<총 페놀릭스 함량>≪ Total phenolic content >
총 페놀릭스 함량은 Folin Denis법(1912)으로 측정하였다. Total phenolic content was measured by Folin Denis method (1912).
구체적으로는 상기에서 준비된 각 분석시료를 시험관에 0.5 ml 분주하고 여기에 25% Na2CO3 용액 0.5 ml를 첨가하여 3분간 정치시켰다. 다시 2N-Folin-Ciocalteu 페놀 시약 0.25 ml를 첨가하여 혼합한 다음 30℃에서 1시간 동안 정치시킨 후 750 nm에서 흡광도를 측정하였다. 이때 총 페놀릭스 함량은 갈산(Gallic acid)을 이용하여 작성한 표준곡선으로부터 함량을 구하여 갈산에 상당하는 양으로 계산하였고 그 결과를 도 3a에 나타냈다.Specifically, 0.5 ml of each analytical sample prepared above was dispensed into a test tube, 0.5 ml of a 25% Na 2 CO 3 solution was added thereto, and the mixture was allowed to stand for 3 minutes. After addition of 0.25 ml of 2N-Folin-Ciocalteu phenol reagent, the mixture was allowed to stand at 30 ° C for 1 hour, and the absorbance was measured at 750 nm. At this time, the total phenolic content was calculated from the standard curve prepared using gallic acid, and the content was calculated as the amount equivalent to gallic acid. The results are shown in FIG.
도 3a에 나타낸 바와 같이, 산양삼 원료에 비교하여, 본 발명에 따른 산양삼 전초차의 총 페놀릭스 함량은 덖음 횟수에 비례하여 증진되었고, 지상부에 총 페놀릭스 함량이 상대적으로 풍부하였고, 혼합한 전초 역시 지하부 보다는 총 페놀릭스 함량이 높았고, 지하부는 1.8∼2.6배 이상, 지상부는 1.2∼1.4배 이상 및 전초는 1.3∼1.6배 이상 증진되었다. As shown in FIG. 3A, the total phenolics content of the goat ginseng outposter according to the present invention was increased in proportion to the number of frying times, the total phenolics content was abundant in the ground portion, and the mixed pre- Total phenolics content was higher than that of the bottom part, 1.8 ~ 2.6 times higher than the ground part, 1.2 ~ 1.4 times higher than the ground part, and 1.3 ~ 1.6 times higher than the outpost.
<총 플라보노이드스 함량>≪ Total flavonoids content >
총 플라보노이드스 함량은 Davis 변법으로 측정하였다. Total flavonoids content was determined by Davis transformation.
구체적으로는 상기에서 준비된 시료 0.1 ml에 1 N NaOH 0.01 ml를 첨가한 후 디에틸렌글리콜 1.0 ml를 첨가하여 37℃에서 1시간 방치 후 420 nm 흡광도를 측정하였다. 이때 총 플라보노이드스 함량은 루틴(rutin)의 최종 농도를 0, 0.25, 0.5, 1.0 mg/ml로 제조하여 작성한 표준곡선으로부터 함량을 구하였고 그 결과는 도 3b에 나타내었다. Specifically, 0.01 ml of 1 N NaOH was added to 0.1 ml of the sample prepared above, 1.0 ml of diethylene glycol was added thereto, and the mixture was allowed to stand at 37 ° C for 1 hour, and the absorbance at 420 nm was measured. At this time, total flavonoids content was determined from the standard curves prepared by making the final concentrations of rutin at 0, 0.25, 0.5, and 1.0 mg / ml, and the results are shown in FIG. 3B.
도 3b에 나타낸 바와 같이, 본 발명에 따른 산양삼 전초차의 총 플라보노이드스 함량도 덖음 횟수에 비례하여 증진되었고 지상부와 전초에 총 플라보노이드 함량이 지하부 보다는 상대적으로 풍부하였고, 지하부는 1.2∼2.3배 이상, 지상부는 1.1∼1.3배 이상 및 전초는 1.3∼1.7배 이상 증진되었다.As shown in FIG. 3B, the total flavonoid content of the goat ginseng extract according to the present invention was also increased in proportion to the number of frying times, and the total flavonoid content in the upper part and the lower part was relatively richer than that in the lower part, Above ground 1.1-1.3 times and outpost 1.3-1.7 times more.
<갈변물질 함량>≪ Browning substance content >
갈변물질의 함량은 비효소적 갈변도 측정 방법을 이용하였다. The content of browning material was measured by non - enzymatic browning method.
구체적으로는 각각의 시료 분말 1 g에 증류수 10 ml를 첨가하여 25℃에서 1시간 추출 후 상등액만을 분광광도계(Spectronic 2D)를 이용하여 420 nm에서 측정하여 그 결과는 도 3c에 나타내었다.Specifically, 10 ml of distilled water was added to 1 g of each sample powder and extracted at 25 ° C for 1 hour. The supernatant was measured at 420 nm using a spectrophotometer (Spectronic 2D). The results are shown in FIG. 3c.
도 3c에 나타낸 바와 같이, 본 발명에 따른 산양삼 전초차의 갈변물질도 덖음 횟수에 비례하여 증진되었고, 지상부와 지하부, 전초 모두 약 1.1배 이상 증진되었다.As shown in FIG. 3C, the browning material of the goat ginseng tea according to the present invention was also increased in proportion to the number of squeezing times, and both the top, bottom, and outposts were increased by about 1.1 times.
시험예 3. 산양삼 전초차의 페놀산 및 플라보놀 분석Test Example 3. Analysis of phenolic acid and flavonol
생리활성성분인 페놀산 및 플라보놀을 분석하였다. The physiologically active components phenolic acid and flavonol were analyzed.
페놀산과 플라보놀 함량 분석은 상기 시험예 2에서와 같이 준비된 각각의 시료에 대해 HPLC(high performance liquid chromatography)를 사용하여 분석하였다. The phenolic acid and flavonol contents were analyzed using HPLC (high performance liquid chromatography) for each sample prepared as in Test Example 2 above.
분석 컬럼은 XBridgeTM C18(4.6×250 mm, 5 μm, Waters Corp., Milford, MA, USA) 컬럼을 사용하였고 0.5% 글라시알 아세트산 (glacial acetic acid, 이동상 용매 A)와 100% 메탄올(이동상 용매 B)을 0 ~ 100% 선형 구배(linear gradient)로 30℃에서 60분간 1분당 1 ml의 속도로 가동하면서 UV 검출기로 페놀산(280 nm)과 플라보놀(270 nm)을 검출하였고 그 결과를 각각 표 3에 나타내었다.The analytical column used was XBridge ™ C18 (4.6 × 250 mm, 5 μm, Waters Corp., Milford, Mass., USA) column and eluted with 0.5% glacial acetic acid (mobile phase solvent A) and 100% (280 nm) and flavonol (270 nm) were detected with a UV detector at a rate of 1 ml per minute for 60 minutes at 30 ° C in a linear gradient of 0-100% Are shown in Table 3, respectively.
표 3에 나타낸 바와 같이, 산양삼 원재료에 비하여, 본 발명에 따른 산양삼 전초차의 페놀산 화합물 화합물인 클로르제닉산 (chlorgenic acid)과 플라보놀 화합물인 쿼르세틴(quercetin)은 지상부 (잎과 줄기)의 경우는 각각 1.1∼1.9배 및 2.5∼3.6배 증가하였고, 지하부 (뿌리)의 경우는 각각 1.7∼2.4배 및 2.7∼3배 증진되었고, 전초 (잎과 줄기, 뿌리)의 경우는 각각 1.4∼2.2배 및 2.7∼3.4배 증진되었다. 특히 지상부의 경우는 덖음 처리가 3회일 때, 지하부는 덖음 횟수가 2회일 때 활성형 진세노사이드가 가장 많이 증진되었다.As shown in Table 3, the phenolic acid compound (chlorgenic acid) and the flavonol compound (quercetin) of the goat germ extractant according to the present invention, compared to the raw material of goat ginseng, (Root, root) increased 1.7 ~ 2.4 times and 2.7 ~ 3 times, respectively, whereas the outbreak (leaf, stem, root) increased 1.4 ~ 2.2 Fold and 2.7 to 3.4 times higher. Especially, in the ground part, the active type ginsenoside was most improved when the roasting was 3 times and the roasting frequency was 2 times.
시험예 4. 산양삼 전초차의 항산화 활성 분석Test Example 4. Antioxidant activity analysis of goat ginseng
본 발명에 따른 산양삼 전초차의 항산화 활성은 DPPH와 ABTS, 하이드록실 (OH) 라디칼 소거활성 및 FRAP 환원력을 측정하여 분석하였다.The antioxidative activities of the ginseng root extract according to the present invention were analyzed by measuring DPPH, ABTS, hydroxyl (OH) radical scavenging activity and FRAP reducing power.
<분석시료><Analytical sample>
시험예 2에서 준비된 각각의 추출물 시료를 60℃에서 감압농축 및 동결건조 후, 0.25 및 1.0 mg/ml 농도로 제조하여 분석시료로 사용하였다.Each of the extract samples prepared in Test Example 2 was concentrated at reduced pressure and lyophilized at 60 ° C, and was used as an assay sample at a concentration of 0.25 and 1.0 mg / ml.
<DPPH 라디칼 소거활성>≪ DPPH radical scavenging activity >
DPPH 라디칼 소거활성은 상기에서 준비된 시료 (1 mg/ml) 0.2 ml에, DPPH 용액(1.5×10-4 M) 0.8 ml를 첨가하여 균일하게 혼합하여 30분간 방치한 후 525 nm에서 흡광도를 측정하여 수행하였다. DPPH 라디칼 소거활성의 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 다음과 같은 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4a에 도시하였다. To DPPH radical scavenging activity, 0.8 ml of DPPH solution (1.5 x 10-4 M) was added to 0.2 ml of the prepared sample (1 mg / ml), and the mixture was homogeneously mixed and left for 30 minutes. Absorbance was measured at 525 nm Respectively. The negative control of the DPPH radical scavenging activity proceeded in the same manner using distilled water instead of the sample, and the difference in absorbance was calculated as a percentage (%) by the following equation, and the result is shown in FIG. 4A.
라디칼 소거활성(%) = [1-(음성대조구 흡광도 ÷ 실험구 흡광도)] × 100Radical scavenging activity (%) = [1- (negative control absorbance / experiment absorbance)] × 100
도 4a에 나타난 바와 같이, 본 발명에 따른 산양삼 전초차의 DPPH 라디칼 소거활성(1 mg/ml 처리)은 덖음 횟수에 비례하여 증진되었고 지상부와 전초에서의 소거활성이 상대적으로 높았고, 원재료에 비하여 약 1.7배(지상부와 지하부, 3회 처리)와 1.9배 (전초, 3회 처리) 이상 증진되었다. As shown in FIG. 4A, the DPPH radical scavenging activity (treated with 1 mg / ml) of the goat ginseng root according to the present invention was increased in proportion to the number of fizzing times, and the scavenging activity was relatively high in the ground and the outpost, 1.7 times (top and bottom, three times) and 1.9 times (top and bottom, three times).
<ABTS 라디칼 소거활성><ABTS radical scavenging activity>
ABTS 라디칼 소거활성은 7 mM ABTS 시약 5 ml과 140 mM K2S2O8 (FW 270.3, Sigma 9392) 5 ml를 섞어 어두운 곳에 16시간 방치시켜 양이온 라디칼을 생성시킨 후, 이를 메탄올로 섞어 732 nm에서 대조구의 흡광도 값이 0.7±0.02가 되도록 조절한 ABTS 용액을 사용하였다. 시료 (0.25 mg/ml 농도) 0.1 ml과 ABTS 용액 0.9 ml를 혼합하여 3분간 반응시키고 732 nm에서 흡광도를 측정하였다. ABTS 라디칼 저해활성 역시 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 상기 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4b에 도시하였다. The ABTS radical scavenging activity was obtained by mixing 5 ml of 7 mM ABTS reagent and 5 ml of 140 mM K 2 S 2 O 8 (FW 270.3, Sigma 9392) in a dark place for 16 hours to produce cation radicals. And the absorbance of the control was adjusted to 0.7 ± 0.02. 0.1 ml of sample (0.25 mg / ml concentration) and 0.9 ml of ABTS solution were mixed and reacted for 3 minutes and absorbance was measured at 732 nm. The ABTS radical inhibitory activity was also measured by the same method using distilled water instead of the sample as the negative control, and the difference in absorbance was calculated as a percentage (%) by the above equation. The results are shown in FIG. 4B.
도 4b에 나타난 바와 같이, 본 발명에 따른 산양삼 전초차의 ABTS 라디칼 소거활성(0.25 mg/ml 처리)은 덖음 횟수에 비례하여 증진되었고 지상부와 전초에서의 소거활성이 상대적으로 높았고, 원재료에 비하여, 약 2배 (지하부, 3회 처리)와 1.5배 (지상부, 3회 처리), 1.6배 (전초, 3회 처리) 이상 증진되었다. As shown in FIG. 4B, the ABTS radical scavenging activity (0.25 mg / ml treatment) of the goat ginseng root according to the present invention was increased in proportion to the number of fizzing times, and the scavenging activity was relatively high in the ground and the outpost, (Overhead, treated 3 times) and 1.5 times (over the ground, treated 3 times) and 1.6 times (outpost, treated 3 times).
<하이드록실(OH) 라디칼 소거활성><Hydroxyl (OH) radical scavenging activity>
하이드록실(OH) 라디칼 소거활성 측정은 10 mM FeSO4 .7H20-EDTA 0.2ml, 10 mM 2-데옥시리보스 0.2 ml, 10 mM H2O2 0.2 ml, 시료 (1 mg/ml) 1.4 ml 혼합한 뒤 37 ℃에서 4시간 동안 반응시켜 혼합액을 만든 후, 이 혼합액에 1% 티오바르비투르산(thiobarbituric acid)/증류수와 2.8% 트리클로로아세트산(trichloroaceric acid)/증류수를 각각 1 ml를 가하여 100 ℃에서 20분간 발색시켜 냉각시킨 후 520 nm에서 흡광도를 측정하여 행하였다. 하이드록실 라디칼 소거활성은 시료 용액의 첨가구와 무첨가구 사이의 흡광도의 차이를 상기 식에 의해 % 값을 산출하였고, 그 결과를 도 4c에 나타냈다.Hydroxyl (OH) radical scavenging activity was measured 10 mM FeSO 4. 0.2 ml of 7H 2 O-EDTA, 0.2 ml of 10 mM 2-deoxyribose, 0.2 ml of 10 mM H 2 O 2 and 1.4 ml of a sample (1 mg / ml) were mixed and reacted at 37 ° C for 4 hours to prepare a mixed solution After adding 1 ml of 1% thiobarbituric acid / distilled water and 2.8% trichloroaceric acid / distilled water to the mixture, the mixture was developed at 100 ° C for 20 minutes, cooled, and then absorbed at 520 nm . The hydroxyl radical scavenging activity was calculated by the above equation using the above equation, and the results are shown in FIG. 4C.
도 4c에 나타난 바와 같이, 본 발명에 따른 산양삼 전초차의 하이드록실 라디칼 소거활성(1 mg/ml 처리)은 덖음 횟수에 비례하여 증진되었고 지상부와 전초에서의 소거활성이 상대적으로 높았고, 원재료에 비하여, 약 1.6배 (지하부, 3회 처리)와 1.4배 (지상부, 3회 처리), 1.5배 (전초, 3회 처리) 이상 증진되었다. As shown in FIG. 4C, the hydroxyl radical scavenging activity (treated with 1 mg / ml) of the goat ginseng root according to the present invention was increased in proportion to the number of times of souring, and the scavenging activity was relatively high in the ground part and the outpost, , 1.4 times (topside treatment, 3 times treatment) and 1.5 times (top treatment, 3 times treatment).
<FRAP 환원력 분석><Analysis of FRAP reduction power>
FRAP (Ferric reducing antioxidant power) 환원력 분석은 화합물의 환원력을 측정하는 방법으로 Fe3+를 Fe2+로 환원시키는 힘을 측정하는 방법이다. 구체적으로는 FeⅢ-TPTZ(ferric tripyridyl triazine)가 시료의 환원력에 의하여 푸른색의 FeⅡ-TPTZ(ferrous tripyridyl triazine)으로 환원될 때 흡광도를 측정하여 항산화 활성을 알아보는 것이다. Ferric reducing antioxidant power (FRAP) is a method for measuring the reducing power of Fe3 + to Fe2 + by measuring the reducing power of a compound. Specifically, FeII-TPTZ (ferric tripyridyl triazine) is reduced to FeII-TPTZ (ferrous tripyridyl triazine) in blue color by the reducing power of the sample.
FRAP 환원력 분석에서 반응액으로는 30 mM 아세테이트 완충액(pH 3.6), 40 mM 염산에 녹인 10 mM 2,4,6-트리피리딜-s-트리아진(TPTZ, T1253, C18H12N6, MW312.33) 및 20 mM FeCl3(F7134, MW 162.20, in DW)를 준비하였으며, 아세테이트 완충액, TPTZ 용액 및 FeCl3 용액을 10:1:1 (v/v/v)로 혼합하여 37 ℃에서 15분간 예비반응을 시켜두었다. 상기에서 준비된 분석시료(0.5 mg/ml 농도) 50 ㎕와 FRAP 시약 950 ㎕를 시험관에 분주한 후, 약 15분간 반응시키고 마이크로플레이트 리더 (Biorad 3055, Sweden)를 사용하여 593 nm에서 흡광도를 측정하여 그 결과를 도 4d에 나타냈다.In the FRAP reduction assay, 30 mM acetate buffer (pH 3.6), 10
도 4d에 도시된 바와 같이, 본 발명에 따른 산양삼 전초차의 FRAP 환원력(0.5 mg/ml 처리)은 덖음 횟수에 비례하여 증진되었고 지상부와 전초에서의 환원력이 상대적으로 높았고, 원재료에 비하여, FRAP 환원력이 매우 높게 나타났다 [3회 덖음시 0.715 (지하부), 1.982 (지상부) 및 0.882 (전초)]As shown in FIG. 4D, the FRAP reducing power (treated with 0.5 mg / ml) of the goat ginseng tea according to the present invention was increased in proportion to the number of fizzing times and the reducing power was relatively high in the ground and the outpost, (3), 0.715 (underground), 1.982 (above ground) and 0.882 (outpost)
이들 결과로부터 본 발명에 따른 산양삼 전초차는 항산화 활성이 현저히 증진됨을 알 수 있다.From these results, it can be understood that the antioxidant activity of the goat ginseng outposter according to the present invention is remarkably enhanced.
시험예 5. 산양삼 전초차의 소화효소 저해활성 검정Test Example 5. Digestive enzyme inhibitory activity assay
본 발명에 따른 산양삼 전초차에 대해 항당뇨(당뇨 개선) 효과의 지표인 알파-글루코시다아제 및 항비만(비만 개선) 효과의 지표인 췌장-리파아제 저해활성을 시험하였다.The pancreatic-lipase inhibitory activity, which is an index of alpha-glucosidase and anti-obesity (anti-obesity) effect, which is an index of antidiabetic effect (diabetic improvement)
<알파-글루코시다아제 저해활성>≪ Alpha-Glucosidase Inhibitory Activity >
알파-글루코시다아제 저해활성은 상기 시험예 4에서 준비된 분석시료 (1 mg/ml 농도) 50 ㎕에 0.5 U/ml 알파-글루코시데이즈 효소액 50 ㎕를 첨가하고 여기에 200 mM 인산나트륨 완충액(pH 6.8) 50 ㎕를 혼합하여 37℃에서 10분간 예비 배양한 후, 인산나트륨 완충액(pH 6.8)을 100 ㎕ 가하여 37℃에서 10분간 반응시켰다. 반응액에 100 mM Na2CO3 0.75 ml를 첨가하여 반응을 정지시키고 420 nm에서 흡광도를 측정하였으며 음성 대조구는 시료 대신 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 다음 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 5a에 도시하였다. The α-glucosidase inhibitory activity was determined by adding 50 μl of 0.5 U / ml α-glucosidease enzyme solution to 50 μl of the analytical sample (1 mg / ml concentration) prepared in Test Example 4 and adding 200 mM sodium phosphate buffer 6.8) were mixed and preliminarily incubated at 37 ° C for 10 minutes. Then, 100 μl of sodium phosphate buffer (pH 6.8) was added and reacted at 37 ° C for 10 minutes. The reaction was stopped by adding 0.75 ml of 100 mM Na 2 CO 3 to the reaction mixture, and the absorbance at 420 nm was measured. Negative control was carried out in the same manner using distilled water instead of the sample, and the difference in absorbance was expressed as a percentage (% ). The results are shown in Fig. 5A.
저해활성(%) = [1-(음성대조구 흡광도 ÷ 실험구 흡광도)] × 100Inhibitory activity (%) = [1- (negative control absorbance / experiment absorbance)] × 100
도 5a에 도시된 바와 같이, 본 발명에 따른 산양삼 전초차는 산양삼 전초 원재료와 비교하여 알파-글루코시다아제 저해활성은 덖음 횟수에 비례하여 증진되었고 지하부보다 지상부와 전초에서의 저해활성이 상대적으로 높았고, 특히 1 mg/ml 농도 기준으로 약 1.7 ~ 2.4배 (지하부 : 뿌리), 1.5 ~ 1.9배 (지상부 : 잎과 줄기) 및 1.4 ~ 1.9배 (전초 : 잎과 줄기, 뿌리) 증진된 것을 확인할 수 있다.As shown in FIG. 5a, the inhibitory activity of alpha-glucosidase was increased in proportion to the number of times of chewing, and the inhibitory activity was higher in the shoot and shoot than in the shoot, Especially, it can be confirmed that the concentration of 1 mg / ml promoted about 1.7 to 2.4 times (root: root), 1.5 to 1.9 times (above ground: leaves and stem) and 1.4 to 1.9 times (outpost: leaves, stem and root) .
<췌장-리파아제 저해활성><Pancreatic-lipase inhibitory activity>
췌장-리파아제 저해활성은 상기 시험예 4에서 준비된 분석시료(1 mg/ml 농도) 50 ㎕, 1.0 U/ml 췌장 리파아제 효소액 50 ㎕, 200 mM 인산나트륨 완충액(pH 6.8) 50 ㎕를 혼합하여 37℃에서 10분간 예비 배양한 후, 인산나트륨 완충액(pH 6.8)을 100 ㎕ 가하여 37℃에서 10 분간 반응시켰다. 이 반응액에 100 mM Na2CO3 0.75 ml를 첨가하여 반응을 정지시키고 420 nm에서 흡광도를 측정하고 음성 대조구는 증류수를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 상기 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 5b에 도시하였다. The pancreatic-lipase inhibitory activity was determined by mixing 50 μl of the analytical sample (1 mg / ml concentration) prepared in Test Example 4, 50 μl of 1.0 U / ml pancreatic lipase enzyme solution and 50 μl of 200 mM sodium phosphate buffer solution (pH 6.8) For 10 minutes, 100 μl of sodium phosphate buffer (pH 6.8) was added, and the mixture was reacted at 37 ° C for 10 minutes. The reaction was stopped by adding 0.75 ml of 100 mM Na 2 CO 3 to the reaction solution, and the absorbance at 420 nm was measured. Negative control was carried out in the same manner using distilled water to determine the difference in absorbance by the above equation (%). And the results are shown in FIG. 5B.
도 5b에 도시된 바와 같이, 본 발명에 따른 산양삼 전초차는 산양삼 전초 원재료와 비교하여, 췌장-리파아제 저해활성이 덖음 횟수에 비례하여 증진되었고 지하부 보다는 지상부와 전초에서의 저해활성이 상대적으로 높았고, 특히 1 mg/ml 농도 기준으로 약 2.3 ~ 4.1배 (지하부 : 뿌리), 1.3 ~ 1.5배 (지상부 : 잎과 줄기) 및 2 ~ 2.6배 (지상부 : 잎과 줄기, 뿌리) 증진된 것을 확인할 수 있다.As shown in FIG. 5B, the pancreatic-lipase inhibitory activity was increased in proportion to the number of times of pancreatic-lipase inhibition compared with the raw material of the goat ginseng outpost according to the present invention, and the inhibitory activity of the pancreatic- It can be confirmed that about 2.3 ~ 4.1 times (root: root), 1.3 ~ 1.5 times (upper part: leaves and stem) and 2 ~ 2.6 times (upper part: leaves, stem, root) were increased in 1 mg / ml concentration.
이들 결과로부터 본 발명에 따른 산양삼 전초차는 알파-글루코시다아제 및 췌장-리파아제 저해활성이 현저히 증진되어 항당뇨 활성 및 항비만 활성이 탁월함을 알 수 있다.From these results, it can be seen that the goat ginseng outposter according to the present invention has remarkably enhanced alpha-glucosidase and pancreatic-lipase inhibitory activity, and thus has excellent antidiabetic activity and anti-obesity activity.
시험예 6. 산양삼 전초차의 기호성 평가Test Example 6. Evaluation of palatability of goat ginseng tea
본 발명에 따른 산양삼 전초차(3회 덖음처리)와 녹차의 기호성을 평가하여 그 결과를 표 4에 나타냈다.Table 3 shows the results of the evaluation of the palatability of green tea and the green tea according to the present invention.
*식품을 전공으로 하는 20명을 대상으로 5점 척도법(매우 좋다 5점, 좋다 4점, 보
통이다 3점, 나쁘다 2점, 매우 나쁘다 1점)으로 기호성 평가를 실시하였음.* The raw goat ginseng tea was originally mixed with the raw weight of goat's ginseng at the weight ratio of 4: 6.
* A score of 5 points for 20 students majoring in food (5 points for very good, 4 points for good,
3 points for bad, 2 points for bad, and 1 point for very bad).
표 4에 나타난 바와 같이, 본 발명에 따라 3회 덖음 처리한 산양삼 전초차의 경우 통상 일반인이 즐겨 마시는 녹차보다 기호성이 휠씬 우수함을 알 수 있다.As shown in Table 4, according to the present invention, it can be seen that the preference of the Korean goat ginseng tea which has been treated with 3 times of shaking is much better than that of green tea which is commonly enjoyed by the general public.
상기 기능성 검정 결과들로부터, 본 발명의 제조방법에 따라 제조된 산양삼 전초차는 활성형 진세노사이드(진세노사이드 F2, Rg3와 Rh2 및 컴파운드 케이), 크롤니제닉산와 커레세틴과 같은 생리활성 성분이 증진될 뿐만 아니라 기호성이 우수하고 항산화 활성, 알파-글루코시다제 저해활성과 췌장 리파제 저해활성도 증진되어 우수한 항산화, 항당뇨 및 항비만 활성을 갖는 기능성 식품의 소재로 유용하다는 것을 알 수 있다.From the functional test results, it was found that the raw goat germ extract prepared according to the production method of the present invention contains a physiologically active ingredient such as active ginsenoside (ginsenoside F2, Rg3 and Rh2 and compound K), crohnic acid and curercetin And is also useful as a material for functional foods having excellent antioxidant, antidiabetic and anti-obesity activity because it has excellent palatability, antioxidative activity, alpha-glucosidase inhibitory activity and pancreatic lipase inhibitory activity.
Claims (7)
i) 산양삼 전초를 80∼100℃에서 20∼60분간 증숙하는 단계;
ii) 증숙된 산양삼 지하부는 180∼220℃에서 5∼15분 덖음 및 40~50℃ 냉각을 2~3회 반복하는 단계;
ⅲ) 증숙된 산양삼 지상부는 130∼160℃에서 5∼15분 덖음 및 40~50℃ 냉각을 2~3회 반복하는 단계; 및
ⅳ) 덖음된 산양삼 지상부와 산양삼 지하부를 혼합하는 단계를 포함하는 것인 제조방법.
A method for producing ginsenosides F2, Rg3, Rh2, and a goat ginseng precursor having enhanced compound k and chlorogenic acid and quercetin,
i) mixing the outpasted ginseng root at 80 to 100 DEG C for 20 to 60 minutes;
ii) repeating the subcultivation of the goat ginseng for 2 to 3 times at 180 to 220 DEG C for 5 to 15 minutes and cooling at 40 to 50 DEG C;
Iii) repeating the step 2 ~ 3 times at a temperature of 130 ~ 160 캜 for 5 ~ 15 minutes and cooling at 40 ~ 50 캜; And
Iv) mixing the ground ginseng root and the ginseng root.
The process according to claim 1, wherein the step of ii) is repeated twice at 200 캜 for 5 to 15 minutes and at 40 to 50 캜 for cooling, the overburden of step iii) is cooled for 5 to 15 minutes at 150 캜, A method for producing ginsenosides F2, Rg3, Rh2, and compound k, chlorogenic acid and quercetin-enhanced goat ginseng, which is repeated three times at 40 to 50 占 폚.
The method of claim 1, wherein the ginsenoside F2, Rg3, Rh2, and Compound K, which are mixed in the step 1), are mixed in a ratio of 1: 10-10: 1 (w / A method for producing an acidic and quercetin-enhanced goat gum outpost.
4. An outpox prepared by the method according to any one of claims 1 to 3, wherein the ginsenosides F2, Rg3, Rh2 and compound k and chlorogenic acid and quercetin are enhanced.
[Claim 5] The method of claim 4, wherein the ginseng root outgrowth comprises at least about 5 mg / g of ginsenoside F2, at least about 0.7 mg / g of ginsenoside Rg3, at least about 0.7 mg / g of ginsenoside compound k, Ginsenosides F2, Rg3, Rh2, which contain about 1 mg / g or more of Rh2 and about 60 占 퐂 / g or more of chlorogenic acid and about 150 占 퐂 / g or more of quercetin, An outpost of goat ginseng with enhanced genic acid and quercetin.
[Claim 7] The ginseng root extract according to claim 5, wherein the ginseng root extract has antioxidative activity, antidiabetic activity, and anti-obesity activity, ginsenoside F2, Rg3, Rh2 and compound k, chlorogenic acid and quercetin-enhanced goat serum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170157205A KR102044607B1 (en) | 2017-11-23 | 2017-11-23 | Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170157205A KR102044607B1 (en) | 2017-11-23 | 2017-11-23 | Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20190059525A true KR20190059525A (en) | 2019-05-31 |
| KR102044607B1 KR102044607B1 (en) | 2019-11-13 |
Family
ID=66657310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170157205A Expired - Fee Related KR102044607B1 (en) | 2017-11-23 | 2017-11-23 | Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102044607B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250038061A (en) | 2023-09-11 | 2025-03-19 | 농업회사법인 허브앤티 주식회사 | Functional food composition for an antioxidant and antiobesity effect containing mountain goat ginseng extracts with increased ginsenoside as an active ingredient and method for its preparation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150010058A (en) * | 2013-07-18 | 2015-01-28 | 김흥수 | Food material and process using ginseng fruit |
| KR20150078612A (en) * | 2013-12-31 | 2015-07-08 | 주식회사 풀무원 | A powder for infusion and improving mouthfeel of Red Ginseng and process for the same |
-
2017
- 2017-11-23 KR KR1020170157205A patent/KR102044607B1/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150010058A (en) * | 2013-07-18 | 2015-01-28 | 김흥수 | Food material and process using ginseng fruit |
| KR20150078612A (en) * | 2013-12-31 | 2015-07-08 | 주식회사 풀무원 | A powder for infusion and improving mouthfeel of Red Ginseng and process for the same |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102044607B1 (en) | 2019-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2001066714A1 (en) | α-amylase activity inhibitor | |
| KR102105111B1 (en) | Energy drink composition containing increased biological active materials and preparation method thereof | |
| KR101963978B1 (en) | Composition of fermented sprout ginseng having increased ginsenosides Rh2 and compound K, bioactive components, and preparation method thereof | |
| KR102335208B1 (en) | Immune enhancing liquid composition having increased ginsenosides Rb1, Rg1 and Rg3 and preparation method thereof | |
| KR20030026939A (en) | The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods | |
| KR102231913B1 (en) | Vegetable Brown Sauce having high biological active materials and preparation method thereof | |
| KR102104175B1 (en) | Method for producing functional fermented dutch coffee | |
| KR101774769B1 (en) | Composition for medicinal herbal tea and manufacturing method of composition for medicinal herbal by supercritical fluid extraction and manufacturing method of carbonated beverage and health beverage thereof | |
| KR101963046B1 (en) | Composition of processed ginseng having increased ginsenoside compound K, chlorgenic acid and quercetin, and preparation method thereof | |
| KR102815040B1 (en) | Method for roasting green coffee bean to improve flavor and coffee using the same | |
| KR20190059525A (en) | Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof | |
| KR101971857B1 (en) | Method for producing functional cabbage juice comprising medicinal herb | |
| KR102007576B1 (en) | Beverage composition of Aronia melanocarpa containing active ginsenosides and preparation method thereof | |
| KR20210072290A (en) | Liquid ginseng composition containing high ginsenoside F2, Rg3 and compound K, chlorogenic acid and quercetin and preparation method thereof | |
| KR20230112583A (en) | Method for manufacturing health functional food containing broccoli stems | |
| KR102464052B1 (en) | Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof | |
| KR101403355B1 (en) | Method for producing dandelion flower Sikhae | |
| KR102007251B1 (en) | Method for preparing the functional mashed adzuki beans using germinated adzuki beans | |
| KR101097664B1 (en) | Method of processing roots of korea ginseng | |
| KR100936600B1 (en) | Red ginseng composition with masked bitterness and preparation method thereof | |
| KR20210143499A (en) | Manufacturing method of health food having antioxidant activity containing fermented polygonum multiflorum complex extracts and the health food having antioxidant activity thereby | |
| KR102889935B1 (en) | Tea with Mugwort as Main Material and Process for Preparing thereof | |
| CN110679688A (en) | Honey oolong tea beverage | |
| Nyehangane et al. | Preparation and health benefits of herbal tea from mulberry leaves | |
| KR102851182B1 (en) | Manufacturing method of mixed garlic and mugwort drinks with enhanced preference and active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R14-asn-PN2301 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20241108 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| H13 | Ip right lapsed |
Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE Effective date: 20241108 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20241108 |